Skip to content

Home/Archive/PubMed

PubMed · 9727881

Learning to use troglitazone.

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Chromans Diabetes Mellitus, Type 2 Humans Hypoglycemic Agents Insulin Resistance Thiazoles Thiazolidinediones Troglitazone Editorial Review Comment

Keep this discovery

Explore connections, maps & timelines

M C Riddle. 1998. Learning to use troglitazone.. https://doi.org/10.2337/diacare.21.9.1389

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Troglitazone, an euglycemic antidiabetic drug.

Troglitazone (or 5-{4-[(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl) methoxy]benzyl}thiazolidine-2,4-dione, C24H27NO5S) is the first euglycemic drug. The molecules are held together in the lattice by intermolecular hydrogen bonds between the hydroxy O atom of the chroman moiety, and the ketone O and ring N atom of the thiazolidine-2,4-dione moiety.

Chromans↗

PubMed1999

FDA drug-review, surveillance processes under scrutiny.

Explore the source record for details and available documents.

Chromans↗

PubMed1999

Significant weight gain with rezulin therapy.

Explore the source record for details and available documents.

Chromans↗